Related Experiment Video
Updated: Oct 26, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Twist1 contributes to developing and sustaining corticosteroid resistance in ulcerative colitis
Changqin Liu1,2,3,4,5, Li-Hua Mo1,2,3,4,5, Bai-Sui Feng1,2,3,4,5
1Department of Gastroenterology, The Shanghai Tenth People's Hospital of Tongji University, Shanghai, China.
Twist1 protein (TW1) drives corticosteroid resistance (CR) in ulcerative colitis (UC) by blocking steroid interaction with the glucocorticoid receptor (GR) in neutrophils. Inhibiting TW1 restores steroid sensitivity in UC models.
Area of Science:
- Gastroenterology
- Immunology
- Molecular Biology
Background:
- Corticosteroid resistance (CR) poses a significant challenge in ulcerative colitis (UC) treatment.
- The precise mechanisms underlying CR in UC remain largely unknown.
- Twist1 protein (TW1), an apoptosis inhibitor with immune regulatory roles, is implicated.
Purpose of the Study:
- To investigate the role of Twist1 protein (TW1) in the development and persistence of corticosteroid resistance (CR) in ulcerative colitis (UC).
Main Methods:
- Neutrophils were isolated from colon tissues of UC patients and a CR colitis mouse model.
- RNA sequencing was used to analyze inflammation-related gene activity.
- A CR colitis mouse model was established using dextran sulfate sodium and hypoxia.
Main Results:
- Elevated TW1 expression was observed in neutrophils from CR UC patients and CR mouse models.
- TW1 physically bound to glucocorticoid receptor-alpha (GRα), hindering steroid binding and abrogating steroid effects.
- STAT3 and Ras protein activator like 1 interaction sustained high TW1 expression in CR neutrophils.
Conclusions:
- High TW1 expression in neutrophils is a hallmark of corticosteroid resistance in UC.
- TW1 interferes with steroid-mediated regulation of neutrophil activity.
- TW1 inhibition successfully restored corticosteroid sensitivity in a CR murine model.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

